Gemer Sita Ir 50/500/1 Mg Tab

Gemer Sita IR 50/500/1 MG Tablet

Gemer Sita IR 50/500/1 MG Tablet is an oral antidiabetic medication manufactured by SUN PHARMA-AZURA DIV., prescribed for the management of Type 2 Diabetes Mellitus. It is a triple-combination therapy used when diet, exercise, and single-agent treatments are insufficient to achieve adequate glycemic control.

Composition Each film-coated tablet of Gemer Sita IR 50/500/1 contains:

• Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 50 mg
• Metformin Hydrochloride IP 500 mg
• Glimepiride IP 1 mg

Uses Gemer Sita IR 50/500/1 is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It works by:

• Stimulating the pancreas to release more insulin (Glimepiride).
• Reducing glucose production by the liver and delaying sugar absorption from the intestine (Metformin).
• Increasing natural substances (incretins) that lower blood sugar when it's high and signaling the liver to stop producing sugar (Sitagliptin). This comprehensive action helps control blood sugar levels throughout the day and reduces the risk of diabetes-related complications such as nerve damage, kidney issues, eye problems, and heart conditions.

Dosage and Administration The usual recommended dose is one tablet twice-daily orally, 15-30 minutes before a meal. The dosage should be individualized based on the patient's current regimen, effectiveness, and tolerability. Do not exceed the maximum recommended daily dose of 100 mg of sitagliptin, 2000 mg of metformin hydrochloride, and 8 mg of glimepiride. Do not crush, break, or chew the tablet.

Side Effects Common side effects include:

• Nausea, vomiting, abdominal pain, diarrhea
• Headache
• Low blood sugar (hypoglycemia), which can cause shakiness, sweating, confusion, and hunger
• Frequent urination
• Allergic reactions
• Nasopharyngitis, upper respiratory tract infection
• Musculoskeletal pain Serious side effects may include lactic acidosis, particularly in patients with kidney or liver impairment.

Precautions

• Allergy: Contraindicated if allergic to sitagliptin, metformin, glimepiride, or any other ingredients.
• Renal Impairment: Assess renal function before and periodically during treatment. Contraindicated in patients with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m². Not recommended for eGFR between 30 and less than 45 mL/min/1.73 m².
• Hepatic Impairment: Not recommended in patients with hepatic impairment due to increased risk of lactic acidosis.
• Pregnancy and Breastfeeding: Not recommended during pregnancy, especially in the second and third trimesters, or while breastfeeding.
• Alcohol Consumption: Avoid alcohol as it increases the risk of hypoglycemia and lactic acidosis.
• Elderly Patients: Use with caution due to higher risk of decreased renal function and hypoglycemia.
• Children: Not recommended for use in pediatric patients under 18 years of age.
• Iodinated Contrast Imaging: Discontinue Gemer Sita IR at the time of, or prior to, an iodinated contrast imaging procedure.
• Drug Interactions: Inform your doctor about all medications, including herbs and supplements, to avoid potential interactions.

Storage Store in a cool and dry place away from sunlight. Keep out of the sight and reach of children. Recommended storage temperatures are between 10ºC to 25ºC or below 30ºC. Protect from moisture and light.

What is GEMER SITA IR 50/500/1 MG Tablet used for?

GEMER SITA IR 50/500/1 MG Tablet is used to manage type 2 diabetes mellitus in adults. It is prescribed when diet, exercise, and single-agent medications are not sufficient to control blood sugar levels effectively. This medicine helps to lower high blood sugar, improve insulin response, and reduce the risk of long-term diabetes complications such as kidney or eye damage.

How does GEMER SITA IR 50/500/1 MG Tablet work?

This medicine is a combination of three active ingredients: Glimepiride, Metformin, and Sitagliptin. Glimepiride works by stimulating the pancreas to release more insulin. Metformin lowers blood sugar by reducing glucose production in the liver, improving insulin sensitivity in muscle cells, and slowing sugar absorption from the gut. Sitagliptin enhances the activity of incretin hormones, which increase insulin release after meals and decrease glucose production by the liver when blood sugar is high.

What is the usual dosage for GEMER SITA IR 50/500/1 MG Tablet?

The usual recommended dose is one tablet twice daily, taken orally 15-30 minutes before a meal. However, the exact dosage and duration of treatment are determined by your doctor based on your individual needs, current regimen, and how well you respond to the medication. It's important not to exceed the maximum recommended daily doses for each component: 100 mg of sitagliptin, 2000 mg of metformin hydrochloride, and 8 mg of glimepiride.

What are the possible side effects of GEMER SITA IR 50/500/1 MG Tablet?

Common side effects may include nausea, diarrhea, abdominal pain, taste changes, flatulence, stomach pain, headache, skin rash, and upper respiratory tract infection. Hypoglycemia (low blood sugar) is also a possible side effect, especially when taken with other antidiabetic medicines or if meals are delayed or missed. More serious, but rare, side effects can include lactic acidosis or severe allergic reactions. If you experience any severe or persistent side effects, consult your doctor immediately.

Is GEMER SITA IR 50/500/1 MG Tablet safe during pregnancy or breastfeeding?

No, GEMER SITA IR 50/500/1 MG Tablet is generally not recommended for use during pregnancy as animal studies have shown harmful effects on the developing baby, and there are limited human studies. It is also not recommended for breastfeeding mothers as components of the medicine may pass into breast milk and potentially harm the baby. Always inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding before taking this medication.

Can GEMER SITA IR 50/500/1 MG Tablet be taken with other medications?

This medicine can interact with certain other medications, potentially affecting its effectiveness or increasing the risk of side effects. Examples include some antifungals (e.g., miconazole, fluconazole), antibiotics (e.g., rifampin, vancomycin), diuretics (e.g., furosemide), certain heart medications, corticosteroids, and anti-psychotics. Always inform your doctor about all the medicines, supplements, or herbal products you are currently taking to avoid potential interactions.

What precautions should be taken while taking GEMER SITA IR 50/500/1 MG Tablet?

Avoid consuming alcohol while taking this medicine, as it can increase the risk of hypoglycemia and lactic acidosis. This medicine is not suitable for individuals with type 1 diabetes mellitus, diabetic ketoacidosis, severe liver or kidney disease, or acute heart problems. Regular monitoring of blood sugar levels is essential. It is also not recommended for children and adolescents under 18 years of age.

What happens if a dose of GEMER SITA IR 50/500/1 MG Tablet is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

How should GEMER SITA IR 50/500/1 MG Tablet be stored?

Store GEMER SITA IR 50/500/1 MG Tablet below 25°C. Keep it in a cool and dry place, away from direct sunlight and moisture. Ensure it is kept out of the sight and reach of children.